IDENTIFYING THE NEUROBEHAVIORAL PHENOTYPE OF FETAL ALCOHOL SPECTRUM DISORDER IN YOUNG CHILDREN
Main Article Content
Keywords
Fetal alcohol spectrum disorder, FASD, neurobehavioral phenotype, Neurodevelopmental Screening Test, NST
Abstract
Background
Most children with Fetal Alcohol Spectrum Disorder (FASD) do not display the typical facial changes, making the diagnosis much more challenging due to poor specificity of the brain dysfunction exhibited by these children. We have recently described and validated a behavioral phenotype of FASD using items from the Child Behavior Checklist (The Neurobehavioral Screening Test, NST). This tool has high sensitivity and specificity in separating children aged 6-13 yrs with FASD from those with ADHD and from healthy controls.
Objectives
To test the validity of the NST for children aged 4-6 years in order to help facilitate diagnosis of FASD in young children.
Methods
Children referred to Motherisk for FASD diagnosis are all tested using the Child Behavior Checklist. We compared the scores of children 4-6 yrs diagnosed with FASD to those referred but not receiving a diagnosis, as well as to normal healthy control children of the same age range.
Results
Out of the 10 items of NST used at age 6-13 years, 3 are not scored in children 4-6 years of age. Using the 7 remaining items, children with FASD endorsed significantly more items (6.7+/-1.3) than healthy controls ( 2.3+/-1.2 ), or alcohol- exposed children who were not given an FASD diagnosis (4.7+/- 1.9). Using a cut-off of 5 out of7 items, the NST had a 94% sensitivity and 96% specificity in identifying children with FASD. Nine of 19 children exposed to alcohol with whom an FASD diagnosis could not be confirmed, scored 5 or more on the NST.
Conclusions
In this pilot study, the NST has shown very high sensitivity and specificity and can be used to identify children who are very likely to be diagnosed with FASD.
References
2. Jacobson SW, Jacobson JL, Sokol RJ, Chiodo LM, Corobana R. Maternal age, alcohol abuse history, and quality of parenting as moderators of the effects of prenatal alcohol exposure on 7.5-year intellectual function. Alcohol Clin Exp Res 2004;28(11):1732–1745.
3. Rasmussen C. Executive functioning and working memory in fetal alcohol spectrum disorder. Alcohol Clin Exp Res 2005;29:1359-1367.
4. Mattson SN, Riley EP. Parent Ratings of Behavior in Children with Heavy Prenatal Alcohol Exposure and IQ-Matched Controls. Alcohol Clin Exp Res 2000; 24(2): 226–231.
5. Niccols A. Fetal alcohol syndrome and the developing socio-emotional brain. Brain Cogn 2007;65(1):135–142.
6. O’Malley KD, Nanson J. Clinical implications of a link between fetal alcohol spectrum disorder and attention-deficit hyperactivity disorder. Can J Psychiatry Rev Can Psychiatr 2002;47(4):349–354.
7. Oesterheld JR, Kofoed L, Tervo R, Fogas B, Wilson A, Fiechtner H. Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: a controlled pilot study. J Child Adolesc Psychopharmacol 1998;8(1):39-48.
8. Steinhausen HC, Willms J, Spohr HL. Longterm psychopathological and cognitive outcome of children with fetal alcohol syndrome. J Am Acad Child Adolesc Psychiatry 1993;32:990-994.
9. O’Connor MJ, Shah B, Whaley S, Cronin P, Gunderson B, Graham J. Psychiatric illness in a clinical sample of children with prenatal alcohol exposure. Am J Drug Alcohol Abuse 2002;28:743-754.
10. Famy C, Streissguth AP, Unis AS. Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects. Am J Psychiatry 1998;155:552-554.
11. Achenbach T, Rescolora A. Child Behavior Checklist for 6-18 Years. 2001. Available at: http://www.aseba.org/forms/schoolagecbcl.pdf
12. Nash K, Rovet J, Greenbaum R, Fantus E, Nulman I, Koren G. Identifying the behavioural phenotype in fetal alcohol spectrum disorder: sensitivity, specificity and screening potential. Arch Womens Ment Health 2006;9(4):181–186.
13. Goh YI, Chudley AE, Clarren SK, et al. Development of Canadian screening tools for fetal alcohol spectrum disorder. Can J Clin Pharmacol 2008;15(2):e344–e366.
14. Nash K, Koren G, Rovet J. A differential approach for examining the behavioural phenotype of fetal alcohol spectrum disorders. J Popul Ther Clin Pharmacol 2012;18(3):e440–453.
15. Rasmussen C. Screening and early assessment for FASD: Links to prevention and intervention. FASD Prevention Conference. Institute of Health Economics, Edmonton, Alberta. September 2013.
16. Fryer SL, McGee CL, Matt GE, Riley EP, Mattson SN. Evaluation of psychopathological conditions in children with heavy prenatal alcohol exposure. Pediatrics 2007; 119:e733-e741.
17. Greenbaum RL, Stevens SA, Nash K, Koren G, Rovet J. Social cognitive and emotion processing abilities of children with fetal alcohol spectrum disorders: a comparison with attention deficit hyperactivity disorder. Alcohol Clin Exp Res 2009;33(10):1656-1670.
18. Rasmussen C, Talwar V, Loomes C, Andrew G. Brief report: lie-telling in children with fetal alcohol spectrum disorder. J Pediatr Psychol 2008; 33(2):220-225.